Mohammad Behdad Jamshidi
Deep Learning Techniques and COVID-19 Drug Discovery: Fundamentals, State-of-the-Art and Future Directions
Jamshidi, Mohammad Behdad; Lalbakhsh, Ali; Talla, Jakub; Peroutka, Zdeněk; Roshani, Sobhan; Matousek, Vaclav; Roshani, Saeed; Mirmozafari, Mirhamed; Malek, Zahra; La Spada, Luigi; Sabet, Asal; Dehghani, Mojgan; Jamshidi, Morteza; Honari, Mohammad Mahdi; Hadjilooei, Farimah; Jamshidi, Alireza; Lalbakhsh, Pedram; Hashemi-Dezaki, Hamed; Ahmadi, Sahar; Lotfi, Saeedeh
Authors
Ali Lalbakhsh
Jakub Talla
Zdeněk Peroutka
Sobhan Roshani
Vaclav Matousek
Saeed Roshani
Mirhamed Mirmozafari
Zahra Malek
Dr Luigi La Spada L.LaSpada@napier.ac.uk
Lecturer
Asal Sabet
Mojgan Dehghani
Morteza Jamshidi
Mohammad Mahdi Honari
Farimah Hadjilooei
Alireza Jamshidi
Pedram Lalbakhsh
Hamed Hashemi-Dezaki
Sahar Ahmadi
Saeedeh Lotfi
Contributors
Ibrahim Arpaci
Editor
Mostafa Al-Emran
Editor
Mohammed A. Al-Sharafi
Editor
Gonçalo Marques
Editor
Abstract
The world is in a frustrating situation, which is exacerbating due to the time-consuming process of the COVID-19 vaccine design and production. This chapter provides a comprehensive investigation of fundamentals, state-of-the-art and some perspectives to speed up the process of the design, optimization and production of the medicine for COVID-19 based on Deep Learning (DL) methods. The proposed platforms are able to be used as predictors to forecast antigens during the infection disregarding their abundance and immunogenicity with no requirement of growing the pathogen in vitro. First, we briefly survey the latest achievements and fundamentals of some DL methodologies, including Deep Boltzmann Machines (DBM), Restricted Boltzmann Machine (RBM), Deep Belief Network (DBN), Hopfield network and Long Short-Term Memory(LSTM). These techniques help us to reach an integrated approach for drug development by non-conventional antigens. We then propose several DL-based platforms to utilize for future applications regarding the latest publications and medical reports. Considering the evolving date on COVID-19 and its ever-changing nature, we believe this survey can give readers some useful ideas and directions to understand the application of Artificial Intelligence (AI) to accelerate the vaccine design not only for COVID-19 but also for many different diseases or viruses.
Citation
Jamshidi, M. B., Lalbakhsh, A., Talla, J., Peroutka, Z., Roshani, S., Matousek, V., Roshani, S., Mirmozafari, M., Malek, Z., La Spada, L., Sabet, A., Dehghani, M., Jamshidi, M., Honari, M. M., Hadjilooei, F., Jamshidi, A., Lalbakhsh, P., Hashemi-Dezaki, H., Ahmadi, S., & Lotfi, S. (2021). Deep Learning Techniques and COVID-19 Drug Discovery: Fundamentals, State-of-the-Art and Future Directions. In I. Arpaci, M. Al-Emran, M. A. Al-Sharafi, & G. Marques (Eds.), Emerging Technologies During the Era of COVID-19 Pandemic (9-31). Springer. https://doi.org/10.1007/978-3-030-67716-9_2
Online Publication Date | Mar 21, 2021 |
---|---|
Publication Date | 2021 |
Deposit Date | Nov 30, 2022 |
Publisher | Springer |
Pages | 9-31 |
Series Title | Studies in Systems, Decision and Control |
Series Number | 348 |
Series ISSN | 2198-4190 |
Book Title | Emerging Technologies During the Era of COVID-19 Pandemic |
ISBN | 978-3-030-67715-2 |
DOI | https://doi.org/10.1007/978-3-030-67716-9_2 |
Keywords | Artificial intelligence, Artificial neural network, Bioinformatics, COVID-19, Deep learning, Drug discovery |
Public URL | http://researchrepository.napier.ac.uk/Output/2968427 |
You might also like
Electromagnetic Nanoparticles for Sensing and Medical Diagnostic Applications
(2018)
Journal Article
Near-zero-index wires.
(2017)
Journal Article
Isotropic and anisotropic surface wave cloaking techniques
(2016)
Journal Article
Metamaterial-based wideband electromagnetic wave absorber
(2016)
Journal Article
Surface plasmon resonance of nanoshell particles with PMMA-graphene core
(2014)
Journal Article